Difficulty: Medium
Average Score: 92%
Practice
In post menopausal women who are receiving estrogen replacement therapy, medroxyprogesterone is administered concurrently to reduce the risk of:
Correct answer
B
Rationale
Progestins like medroxyprogesterone reduce estrogen-induced endometrial hyperplasia and cancer risk.